当前位置:首页 - 行情中心 - 康拓医疗(688314) - 财务分析 - 现金流量表

康拓医疗

(688314)

  

流通市值:27.40亿  总市值:27.40亿
流通股本:8123.92万   总股本:8123.92万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金277,982,714.47187,723,096.3192,033,729.75367,834,458.62
  收到其他与经营活动有关的现金9,117,050.367,982,279.092,367,824.9119,255,425.56
  经营活动现金流入小计287,099,764.83195,705,375.494,401,554.66387,089,884.18
  购买商品、接受劳务支付的现金46,688,064.2229,868,048.8319,630,189.3245,307,204.23
  支付给职工以及为职工支付的现金61,351,111.7643,375,022.9224,814,828.1777,971,565.8
  支付的各项税费39,683,723.1526,320,887.2712,247,603.0153,964,567
  支付其他与经营活动有关的现金53,293,320.1333,951,560.7315,681,528.4269,591,992.27
  经营活动现金流出小计201,016,219.26133,515,519.7572,374,148.92246,835,329.3
  经营活动产生的现金流量净额86,083,545.5762,189,855.6522,027,405.74140,254,554.88
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,161,679.21699,155.63332,721.652,207,588.54
  处置固定资产、无形资产和其他长期资产收回的现金净额2,8002,8001,500661,079.18
  收到的其他与投资活动有关的现金628,000,000468,000,000227,000,000665,000,000
  投资活动现金流入小计629,164,479.21468,701,955.63227,334,221.65667,868,667.72
  购建固定资产、无形资产和其他长期资产支付的现金36,463,636.2220,578,374.339,596,251.7247,397,964.73
  投资支付的现金27,747,37415,000,00015,000,00032,848,390
  取得子公司及其他营业单位支付的现金00010,775,066.87
  支付其他与投资活动有关的现金758,000,000538,000,000308,000,000668,202,515
  投资活动现金流出小计822,211,010.22573,578,374.33332,596,251.72759,223,936.6
  投资活动产生的现金流量净额-193,046,531.01-104,876,418.7-105,262,030.07-91,355,268.88
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金32,252,025.0915,548,333.98465,020.7342,695,997.09
  支付其他与筹资活动有关的现金1,325,669.041,843,369652,270.533,250,214.44
  筹资活动现金流出小计33,577,694.1317,391,702.981,117,291.2645,946,211.53
  筹资活动产生的现金流量净额-33,577,694.13-17,391,702.98-1,117,291.26-45,946,211.53
四、汇率变动对现金及现金等价物的影响-28,578.29156,466.3473,572.93-329,516.43
五、现金及现金等价物净增加额-140,569,257.86-59,921,799.69-84,278,342.662,623,558.04
  加:期初现金及现金等价物余额377,743,344.37377,743,344.37377,743,344.37375,119,786.33
  期末现金及现金等价物余额237,174,086.51317,821,544.68293,465,001.71377,743,344.37
补充资料:
  净利润-54,519,423.06-87,635,989.83
  资产减值准备-778,139.74-5,341,474.23
  固定资产和投资性房地产折旧-3,978,815.88-7,417,690.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,978,815.88-7,417,690.45
  无形资产摊销-2,253,378.88-4,089,956
  长期待摊费用摊销-1,670,705.5-3,429,793.94
  处置固定资产、无形资产和其他长期资产的损失-0--463,920.09
  固定资产报废损失-13,476.46-21,623.82
  公允价值变动损失-857,482.9-0
  财务费用-1,134,572.27-2,174,544.63
  投资损失-6,366,153.01-12,589,836.25
  递延所得税--410,873.15--1,405,643.35
  其中:递延所得税资产减少-33,722.54--802,493.66
    递延所得税负债增加--444,595.69--603,149.69
  存货的减少--935,076.52-6,778,111.77
  经营性应收项目的减少--4,293,655.23-2,910,474.29
  经营性应付项目的增加--5,682,062.6-6,469,500.25
  其他-570,085.55-0
  债务转为资本---0
  一年内到期的可转换公司债券---0
  融资租入固定资产---0
  现金的期末余额-317,821,544.68-377,743,344.37
  减:现金的期初余额-377,743,344.37-375,119,786.33
  加:现金等价物的期末余额---0
  减:现金等价物的期初余额---0
  现金及现金等价物的净增加额--59,921,799.69-2,623,558.04
公告日期2025-10-282025-08-292025-04-292025-03-28
审计意见(境内)标准无保留意见
TOP↑